Swedish Orphan Biovitrum AB: Sobi to streamline nirsevimab contractual arrangements

Nirsevimab economics simplified through a new royalty agreement with Sanofi and the termination of the participation agreement with AstraZeneca Alignment will provide Sobi benefit through

Related Keywords

Stockholm ,Sweden ,Australia ,United States ,America ,Thomas Kudsk Larsen ,Prnewswire Sobi ,Youtube ,Astrazeneca ,Sobi Investor Relations Team ,Linkedin ,North America ,Middle East ,Sobi Media ,Swedish ,Orphan ,Iovitrum ,Gobi ,Treamline ,Nirsevimab ,Contractual ,Arrangements ,